Please login to the form below

Boehringer Ingelheim

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Boehringer Ingelheim's 2013 sales performance.

Could formulary intelligence be your brand differentiator?

Spiolto – a LAMA/LABA combination for COPD and heir to Boehringer’s blockbuster Spiriva.

AZ’s Farxiga cuts risk of death in chronic kidney disease

In March, the US Food and Drug Administration (FDA) fast-tracked Farxiga’s rival Jardiance (empagliflozin), co-developed by Eli Lilly and Boehringer Ingelheim, to reduce the risk of kidney disease ... Lilly/Boehringer are studying Jardiance in the

AI: the smart money is on the smart thinking

For example, the aforementioned BenevolentAI has arrangements in place with Novartis and AstraZeneca (the latter also works with DeepMatter), while Boehringer Ingelheim has a partnership with Insilico Medicine.

Boehringer/Lilly's Jardiance hits the mark in pivotal heart failure trial

Boehringer Ingelheim and Eli Lilly’s heart failure drug Jardiance reduced the risk of cardiovascular death or hospitalisation due to heart failure in adult patients with and without diabetes – an important ... metabolism and respiratory medicine at

IFPMA launches AMR Action Fund to tackle antimicrobial resistance

German drug developer Boehringer Ingelheim has also contributed $50m to the AMR Action Fund to boost the development of novel treatments against the global health threat.

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

Data provided by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology